Literature DB >> 21856296

Nkx2.2 and Arx genetically interact to regulate pancreatic endocrine cell development and endocrine hormone expression.

Teresa L Mastracci1, Crystal L Wilcox2, Luis Arnes1, Casandra Panea1, Jeffrey A Golden2, Catherine Lee May3, Lori Sussel4.   

Abstract

Nkx2.2 and Arx are essential pancreatic transcription factors. Nkx2.2 is necessary for the appropriate specification of the islet alpha, beta, PP and epsilon cell lineages, whereas Arx is required to form the correct ratio of alpha, beta, delta and PP cells. To begin to understand the cooperative functions of Nkx2.2 and Arx in the development of endocrine cell lineages, we generated progenitor cell-specific deletions of Arx on the Nkx2.2 null background. The analysis of these mutants demonstrates that expansion of the ghrelin cell population in the Nkx2.2 null pancreas is not dependent on Arx; however, Arx is necessary for the upregulation of ghrelin mRNA levels in Nkx2.2 mutant epsilon cells. Alternatively, in the absence of Arx, delta cell numbers are increased and Nkx2.2 becomes essential for the repression of somatostatin gene expression. Interestingly, the dysregulation of ghrelin and somatostatin expression in the Nkx2.2/Arx compound mutant (Nkx2.2(null);Arx(Δpanc)) results in the appearance of ghrelin+/somatostatin+ co-expressing cells. These compound mutants also revealed a genetic interaction between Nkx2.2 and Arx in the regulation of the PP cell lineage; the PP cell population is reduced when Nkx2.2 is deleted but is restored back to wildtype numbers in the Nkx2.2(null);Arx(Δpanc) mutant. Moreover, conditional deletion of Arx in specific pancreatic cell populations established that the functions of Arx are necessary in the Neurog3+ endocrine progenitors. Together, these experiments identify novel genetic interactions between Nkx2.2 and Arx within the endocrine progenitor cells that ensure the correct specification and regulation of endocrine hormone-producing cells. 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21856296      PMCID: PMC3192309          DOI: 10.1016/j.ydbio.2011.08.001

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  48 in total

1.  Ultrastructural studies of the ontogeny of fetal human and porcine endocrine pancreas, with special reference to colocalization of the four major islet hormones.

Authors:  A Lukinius; J L Ericsson; L Grimelius; O Korsgren
Journal:  Dev Biol       Date:  1992-10       Impact factor: 3.582

2.  The midgestational human fetal pancreas contains cells coexpressing islet hormones.

Authors:  R R De Krijger; H J Aanstoot; G Kranenburg; M Reinhard; W J Visser; G J Bruining
Journal:  Dev Biol       Date:  1992-10       Impact factor: 3.582

3.  Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development.

Authors:  Catherine L Prado; Aimee E Pugh-Bernard; Lynda Elghazi; Beatriz Sosa-Pineda; Lori Sussel
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-17       Impact factor: 11.205

4.  Opposing actions of Arx and Pax4 in endocrine pancreas development.

Authors:  Patrick Collombat; Ahmed Mansouri; Jacob Hecksher-Sorensen; Palle Serup; Jens Krull; Gerard Gradwohl; Peter Gruss
Journal:  Genes Dev       Date:  2003-10-15       Impact factor: 11.361

5.  Neuroanatomical distribution of ARX in brain and its localisation in GABAergic neurons.

Authors:  Karine Poirier; Hilde Van Esch; Gaëlle Friocourt; Yoann Saillour; Nadia Bahi; Stéphanie Backer; Evelyne Souil; Laetitia Castelnau-Ptakhine; Cherif Beldjord; Fiona Francis; Thierry Bienvenu; Jamel Chelly
Journal:  Brain Res Mol Brain Res       Date:  2004-03-17

6.  Neurogenin 3-expressing progenitor cells in the gastrointestinal tract differentiate into both endocrine and non-endocrine cell types.

Authors:  Susan E Schonhoff; Maryann Giel-Moloney; Andrew B Leiter
Journal:  Dev Biol       Date:  2004-06-15       Impact factor: 3.582

7.  Ghrelin is expressed in a novel endocrine cell type in developing rat islets and inhibits insulin secretion from INS-1 (832/13) cells.

Authors:  N Wierup; S Yang; R J McEvilly; H Mulder; F Sundler
Journal:  J Histochem Cytochem       Date:  2004-03       Impact factor: 2.479

8.  Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.

Authors:  Sunil R Hingorani; Emanuel F Petricoin; Anirban Maitra; Vinodh Rajapakse; Catrina King; Michael A Jacobetz; Sally Ross; Thomas P Conrads; Timothy D Veenstra; Ben A Hitt; Yoshiya Kawaguchi; Don Johann; Lance A Liotta; Howard C Crawford; Mary E Putt; Tyler Jacks; Christopher V E Wright; Ralph H Hruban; Andrew M Lowy; David A Tuveson
Journal:  Cancer Cell       Date:  2003-12       Impact factor: 31.743

9.  Notochord to endoderm signaling is required for pancreas development.

Authors:  S K Kim; M Hebrok; D A Melton
Journal:  Development       Date:  1997-11       Impact factor: 6.868

10.  PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum.

Authors:  M F Offield; T L Jetton; P A Labosky; M Ray; R W Stein; M A Magnuson; B L Hogan; C V Wright
Journal:  Development       Date:  1996-03       Impact factor: 6.868

View more
  28 in total

1.  Nkx2.2:Cre knock-in mouse line: a novel tool for pancreas- and CNS-specific gene deletion.

Authors:  Dina A Balderes; Mark A Magnuson; Lori Sussel
Journal:  Genesis       Date:  2013-10-01       Impact factor: 2.487

2.  Neurog3-Independent Methylation Is the Earliest Detectable Mark Distinguishing Pancreatic Progenitor Identity.

Authors:  Jing Liu; Amrita Banerjee; Charles A Herring; Jonathan Attalla; Ruiying Hu; Yanwen Xu; Qiujia Shao; Alan J Simmons; Prasanna K Dadi; Sui Wang; David A Jacobson; Bindong Liu; Emily Hodges; Ken S Lau; Guoqiang Gu
Journal:  Dev Cell       Date:  2019-01-07       Impact factor: 12.270

3.  Converting Adult Pancreatic Islet α Cells into β Cells by Targeting Both Dnmt1 and Arx.

Authors:  Harini Chakravarthy; Xueying Gu; Martin Enge; Xiaoqing Dai; Yong Wang; Nicolas Damond; Carolina Downie; Kathy Liu; Jing Wang; Yuan Xing; Simona Chera; Fabrizio Thorel; Stephen Quake; Jose Oberholzer; Patrick E MacDonald; Pedro L Herrera; Seung K Kim
Journal:  Cell Metab       Date:  2017-02-16       Impact factor: 27.287

4.  Glucagon is essential for alpha cell transdifferentiation and beta cell neogenesis.

Authors:  Lihua Ye; Morgan A Robertson; Daniel Hesselson; Didier Y R Stainier; Ryan M Anderson
Journal:  Development       Date:  2015-04-15       Impact factor: 6.868

5.  The Endocrine Pancreas: insights into development, differentiation and diabetes.

Authors:  Teresa L Mastracci; Lori Sussel
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2012-03-14

6.  Arx is required for normal enteroendocrine cell development in mice and humans.

Authors:  Aiping Du; Kyle W McCracken; Erik R Walp; Natalie A Terry; Thomas J Klein; Annie Han; James M Wells; Catherine Lee May
Journal:  Dev Biol       Date:  2012-02-24       Impact factor: 3.582

7.  Loss of mTORC1 signaling alters pancreatic α cell mass and impairs glucagon secretion.

Authors:  Nadejda Bozadjieva; Manuel Blandino-Rosano; Jennifer Chase; Xiao-Qing Dai; Kelsey Cummings; Jennifer Gimeno; Danielle Dean; Alvin C Powers; George K Gittes; Markus A Rüegg; Michael N Hall; Patrick E MacDonald; Ernesto Bernal-Mizrachi
Journal:  J Clin Invest       Date:  2017-11-06       Impact factor: 14.808

8.  Generation of mice encoding a conditional allele of Nkx2.2.

Authors:  Teresa L Mastracci; Chyuan-Sheng Lin; Lori Sussel
Journal:  Transgenic Res       Date:  2013-03-15       Impact factor: 2.788

9.  Pancreatic β cell identity requires continual repression of non-β cell programs.

Authors:  Giselle Domínguez Gutiérrez; Aaron S Bender; Vincenzo Cirulli; Teresa L Mastracci; Stephen M Kelly; Aristotelis Tsirigos; Klaus H Kaestner; Lori Sussel
Journal:  J Clin Invest       Date:  2016-12-12       Impact factor: 14.808

10.  Pancreas-specific deletion of mouse Gata4 and Gata6 causes pancreatic agenesis.

Authors:  Shouhong Xuan; Matthew J Borok; Kimberly J Decker; Michele A Battle; Stephen A Duncan; Michael A Hale; Raymond J Macdonald; Lori Sussel
Journal:  J Clin Invest       Date:  2012-09-24       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.